Contribution of platelets to tumour metastasis.
TLDR
Contributions of platelets to tumour cell survival and spread suggest platelets as a new avenue for therapy.Abstract:
Experimental evidence suggests that platelets contribute to metastasis through adhesive and haemostatic functions that promote cancer cell survival, immune evasion and interactions with vascular cells to assist organ colonization from the bloodstream. Extensive experimental evidence shows that platelets support tumour metastasis. The activation of platelets and the coagulation system have a crucial role in the progression of cancer. Within the circulatory system, platelets guard tumour cells from immune elimination and promote their arrest at the endothelium, supporting the establishment of secondary lesions. These contributions of platelets to tumour cell survival and spread suggest platelets as a new avenue for therapy.read more
Citations
More filters
Journal ArticleDOI
Platelets in liver disease, cancer and regeneration.
TL;DR: Experimental evidence of platelets improving liver fibrosis and accelerating liver regeneration is summarized and addressed based on studies conducted in the laboratory and current progress reports from other investigators, and a novel application of platelet-based clinical therapies to treat liver disease is anticipated.
Journal ArticleDOI
Reprogramming during epithelial to mesenchymal transition under the control of TGFβ
TL;DR: Research on breast cancer EMT/MET aims at delivering biomolecules that can be used diagnostically in cancer pathology and possibly provide ideas for how to improve breast cancer therapy.
Book ChapterDOI
Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment.
TL;DR: This chapter discusses the intravascular microenvironment that the circulating tumor cells must endure and illustrates various aspects of theIntravascular transport of circulating tumor Cells using a mathematical model based on immersed boundary principles.
Journal ArticleDOI
Delivery Strategies for Immune Checkpoint Blockade.
TL;DR: A brief review summarizes strategies to increase the antitumor immunity, including the local and targeted delivery of checkpoint inhibitors, and a combination of different checkpoint inhibitors or with other therapeutic treatments.
Journal ArticleDOI
Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.
Cristina Federici,Eriomina Shahaj,Serena Cecchetti,Serena Camerini,Marialuisa Casella,Elisabetta Iessi,Chiara Camisaschi,Giovanni Paolino,Stefano Calvieri,Simona Ferro,Agata Cova,Paola Squarcina,Lucia Bertuccini,Francesca Iosi,Veronica Huber,Luana Lugini +15 more
TL;DR: Healthy donors' NKEVs displayed main stimulatory functions in peripheral blood mononuclear cells, inducing the expression of human leukocyte antigen DR isotype (HLA-DR) and costimulatory molecules on monocytes and CD25 expression on T cells, suggesting that effects mediated by NkeVs might be potentially exploited in support of cancer therapy.
References
More filters
Journal ArticleDOI
Tumor Angiogenesis: Therapeutic Implications
TL;DR: This new capillary growth is even more vigorous and continuous than a similar outgrowth of capillary sprouts observed in 2016 and is likely to be accompanied by neovascularization.
Journal ArticleDOI
Cancer Metastasis: Building a Framework
Gaorav P. Gupta,Joan Massagué +1 more
TL;DR: Understanding of the origins and nature of cancer metastasis and the selection of traits that are advantageous to cancer cells is promoted.
Journal ArticleDOI
Dissemination and growth of cancer cells in metastatic sites
TL;DR: Inhibition of the growth of metastases in secondary sites offers a promising approach for cancer therapy and could help to improve the treatment of metastatic disease.
Journal ArticleDOI
Microenvironmental regulation of metastasis
TL;DR: Experimental data demonstrating the role of the microenvironment in metastasis is described, areas for future research are identified and possible new therapeutic avenues are suggested.
Journal ArticleDOI
Integrins in cancer: biological implications and therapeutic opportunities
TL;DR: Clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.